Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2
Frequently Asked Questions
What is Market Cap of Avenue Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Avenue Therapeutics Inc market cap is $2.55M.
What is the 52-week high for Avenue Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Avenue Therapeutics Inc 52 week high is $2.70 as of September 27, 2025.
What is the 52-week low for Avenue Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Avenue Therapeutics Inc 52 week low is $0.1653 as of September 27, 2025.
What is Avenue Therapeutics Inc stock price today?
Avenue Therapeutics Inc stock price today is $0.80.
What was Avenue Therapeutics Inc stock price yesterday?
Avenue Therapeutics Inc stock price yesterday was $0.8995.
What is the PE ratio of Avenue Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Avenue Therapeutics Inc’s P/E ratio is -0.25.
What is the Price-to-Book ratio of Avenue Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Avenue Therapeutics Inc P/B ratio is 0.6276.
What is the 50-day moving average of Avenue Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Avenue Therapeutics Inc 50-day moving average is $0.6059.
How many employess does Avenue Therapeutics Inc has?